MP George Freeman says the failed Pfizer bid for Astrazeneca is not a lost opportunity . Instead , these companies have now become reliant on the smaller and more innovative biotechs ( and increasingly charities ) to fill their pipelines with a new world of genetically targeted medicines . Instead , it is a focus on the crusade to make the UK a centre for intelligent design . Freeman says the UK must add to its public health service to boost research . That will ensure the debate continues to be around big business in the UK .
MP George Freeman says the failed Pfizer bid for Astrazeneca is not a lost opportunity . Instead , it is a focus on the crusade to make the UK a centre for intelligent design . Freeman says the UK must add to its public health service to boost research . That will ensure the debate continues to be around big business in the UK .